secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0000950170-22-025442
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Athira Pharma amends bylaws for SEC Rule 14a-19 compliance and advance notice updates
--------------------------------------------------------------------------------

- Board approved amended and restated bylaws effective November 15, 2022.
- Changes comply with new SEC Rule 14a-19 (universal proxy) and enhance advance notice for stockholder proposals and nominations.
- Bylaws updated for recent Delaware General Corporation Law amendments on stockholder meetings.
- Modifications to officer appointments, board committee procedures, and forum selection clause.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000095017022025442/0000950170-22-025442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000095017022025442/atha-20221115.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-025442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer